Study Compares Baricitinib to Dexamethasone for COVID-19
Baricitinib plus remdesivir shows similar efficacy but better safety profile than dexamethasone plus remdesivir in hospitalized adults
Progress Seen in Proportion of Pregnant Persons With Hep C Screening
Percentage undergoing HCV screening test increased from 16.6 percent in quarter 1 of 2011 to 40.6 percent in quarter 2 of 2021
With CDC Approval, COVID-19 Shots for Under 5s Ready for Delivery
Health officials have said the federal government will be ready to ship doses out this week
FDA Approves Pfizer, Moderna Shots for Those 5 Years and Younger
U.S. Centers for Disease Control and Prevention will vote on Saturday on whether to endorse the shots
Medicaid Expansion Buffered Health Coverage Loss During Pandemic
Workers who lived in Medicaid expansion states were 5.4 percent more likely to enroll in Medicaid after job loss during pandemic
Disparities in Life Expectancy by Race, Ethnicity, County Persist
In the U.S., increases in life expectancy were seen for Black, API, Latino, White populations, but no change seen for AIAN
Chronically Ill WTC Responders Face Higher Risk for Severe COVID-19
World Trade Center responders with exposure-related chronic conditions also more likely to experience long COVID
IV Vitamin C Increases Risk for Death, Organ Failure in Sepsis
Risk increased with intravenous vitamin C versus placebo for adults with sepsis in the ICU receiving vasopressor therapy
No Fewer Deaths Seen With Restricted IV Fluid for Septic Shock
Rates of death at 90 days, SAEs did not differ for patients with septic shock receiving restricted versus standard IV fluid therapy in the ICU
Protection Against Omicron Strongest With Hybrid Immunity
Immunity resulting from previous COVID-19 infection and recent booster vaccination confers strongest protection against omicron infection
